Clinical Trial Update: GPC3-CAR-T Cells for Immunotherapy of Cancer With GPC3 Expression [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating GPC3-CAR-T cell therapy for glypican-3 expressing cancers. The study includes hepatocellular carcinoma and squamous cell carcinoma of t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Squamous Cell Carcinoma of the Lung

Drugs mentioned

• GPC3-CAR-T cells (glypican-3-targeted chimeric antigen receptor T cells)

Snippet

Sponsor: Second Affiliated Hospital of Guangzhou Medical University | Conditions: Hepatocellular Carcinoma, Immunotherapy | Phase 1 | Status: RECRUITING